SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Eagle Point Trinity issued 46,277.49 common shares for $473,993 in aggregate proceeds pursuant to subscription agreements, with the sale exempt from Securities Act registration under Section 4(a)(2), Regulation D, and/or Regulation S. This unregistered equity issuance dilutes existing shareholders' ownership and affects net asset value per share.
View raw filing on EDGAR →The Trust issued 296,200 shares in private placement transactions to accredited investors under Rule 506(c) of Regulation D, exempt from Securities Act registration. The filing explicitly discloses unregistered equity sales totaling $1,306,098 in aggregate value, representing a material capital raise. This is a classic dilutive issuance disclosure under Item 3.02, with the Trust's outstanding share count increasing to 2,693,500 shares as of the filing date.
View raw filing on EDGAR →The Company is conducting a continuous private placement of Common Shares under Section 4(a)(2) and Regulation D, with approximately $3.4 million in subscriptions received on August 1, 2026, and plans to continue monthly sales at NAV.
View raw filing on EDGAR →The Company disclosed a continuous private placement of Common Shares under Section 4(a)(2) and Regulation D, with approximately $8.5 million in subscriptions received on August 1, 2026, and an intention to continue selling shares monthly at NAV.
View raw filing on EDGAR →Santander Holdings USA consummated a private placement of 500,000 shares of Series J Preferred Stock to its parent company Banco Santander, S.A., raising $500 million in capital. The transaction relied on the Section 4(a)(2) private placement exemption and was completed on August 27, 2026.
View raw filing on EDGAR →Kazia furnished a confidential investor presentation dated August 27, 2026, in connection with a proposed equity offering (registration statement File No. 333-294392), disclosing clinical trial data, pipeline information, and financial position including approximately $46 million in cash and runway to 2029.
View raw filing on EDGAR →Greenland Mines announced the pricing and launch of a registered public offering of 4,000,000 shares of common stock and pre-funded warrants generating approximately $20 million in gross proceeds under an effective Form S-3 shelf registration statement, with A.G.P./Alliance Global Partners as the sole placement agent.
View raw filing on EDGAR →The filing announces a PIPE (Private Investment in Public Equity) financing transaction in which Alpha Modus is issuing securities to investors in exchange for Bitcoin assets. The press release explicitly references a "Securities Purchase Agreement" and "Warrant for the Purchase of Shares of Class A Common Stock," indicating an unregistered equity issuance. The transaction is material—adding over $200 million in Bitcoin assets and intended to address a Nasdaq listing deficiency—and represents a classic dilutive capital raise at a small-cap issuer.
View raw filing on EDGAR →The filing discloses an unregistered issuance of 4,500 shares of Series B Convertible Preferred Stock in a transaction exempt from registration under Section 4(a)(2) and Regulation D. The preferred stock is convertible into common stock at $3.88 per share, subject to a 19.99% beneficial ownership limitation. Item 3.02 explicitly identifies this as an "Unregistered Sales of Equity Securities," and the restricted nature of the securities combined with the conversion feature and related-party nature (lender owned by chairman Donald P. Monaco) makes this a material dilutive issuance typical of small-cap financing activity.
View raw filing on EDGAR →Worksport entered into a warrant exercise inducement offer on August 27, 2026, whereby it agreed to issue 4,800,526 new Inducement Warrants (representing 125% of the 3,840,421 Warrant Shares exercised) in exchange for the exercise of existing warrants at a reduced price of $0.60 per share. The filing explicitly discloses under Item 3.02 that the Inducement Warrants were issued pursuant to Section 4(a)(2) exemption and are unregistered securities. This is a classic dilutive private placement of equity securities designed to raise approximately $2.3 million in gross proceeds, with the company committing to register the resale of the new warrant shares within 60 days.
View raw filing on EDGAR →The filing discloses a private placement of 8,000,000 shares of common stock and 8,000,000 warrants at $0.05 per share for gross proceeds of $400,000, conducted pursuant to Section 4(a)(2) and Rule 506(b) of Regulation D. This is an unregistered sale of equity securities (Item 3.02) that is dilutive to existing shareholders and represents a material capital-raising transaction typical of small-cap issuers in financial need.
View raw filing on EDGAR →The filing discloses an unregistered issuance of 2,152,853 common shares to DWM Properties LLC (controlled by CEO Danny Meeks) in exchange for satisfaction of a $5.4M promissory note and $2.6M in related-party amounts. Item 3.02 explicitly confirms reliance on Section 4(a)(2), Regulation D, and Section 3(a)(9) exemptions from registration. This is a material dilutive equity issuance to settle debt, typical of financial distress at smaller issuers.
View raw filing on EDGAR →RedCloud announced a private placement of 7.2 million unregistered ordinary shares to company insiders (Christina Byland and Dr. Nikolaus Senn) at $0.25 per share, generating approximately $1.8 million in gross proceeds. The shares are explicitly stated as "unregistered" and the disclosure emphasizes they "have not been registered under the Securities Act of 1933" and "may not be offered or sold in the United States absent registration or an applicable exemption." This is a classic dilutive equity issuance to insiders, material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →Carlyle Credit Solutions completed an unregistered sale of 920,180 shares of Class I common stock for $16.6 million pursuant to Section 4(a)(2) and Regulation D, representing a discrete private placement transaction.
View raw filing on EDGAR →The Company disclosed its ongoing 'New Continuous Offering' of unregistered Class I Common Stock shares on a continuous basis, with 68.3 million shares issued for $1.3 billion in total consideration as part of an active capital-raising program.
View raw filing on EDGAR →The Company issued 14,737 shares of Series B Convertible Preferred Stock to Omnia upon achievement of a milestone under the Omnia Venture Agreements. The issuance was made pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D, which are classic exemptions for unregistered private placements. The Series B Preferred Stock is convertible into common stock at $22.50 per share, creating dilution to existing shareholders. This is a textbook dilutive equity issuance disclosed under Item 3.02.
View raw filing on EDGAR →Southern Cross Acquisition II Corp. completed an unregistered private sale of 224,932 units to the Sponsor and Representative for $2,249,320 pursuant to Section 4(a)(2) exemption, concurrent with the IPO. This classic dilutive private placement allows insiders to acquire equity at the same price as public investors but with transfer restrictions.
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities totaling approximately $247.7 million across three share classes (Class I-Series 1, Class S, and Class D shares) to investors on August 3, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement that materially increases the company's capitalization and is disclosed under Item 3.02, the standard Item for unregistered equity issuances.
View raw filing on EDGAR →The filing discloses an unregistered sale of equity securities totaling approximately $255.7 million across multiple share classes (Class I-Series 1, Class U, Class D, and Class S Shares) to investors on August 3, 2026, exempt under Section 4(a)(2) and Regulations D and S. This is a classic dilutive private placement. The company notes it has sold approximately $10.6 billion in shares since inception as part of a continuous private offering, indicating material ongoing capital raising activity that would affect investor assessment of ownership dilution and the company's capital structure.
View raw filing on EDGAR →Alibaba disclosed a placement of 710,000,000 new ordinary shares (3.7% of pre-existing issued shares) under the General Mandate on 26 August 2026 at HKD 112.7 per share, increasing total issued shares from 19.17 billion to 19.88 billion. This is a material dilutive equity issuance that increases the share count and would affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →Swvl Holdings Corp completed a strategic investment round totaling $14.5 million through multiple private placements of ordinary shares at approximately $1.446 per share under Section 4(a)(2) and Rule 506(b) exemptions. The round included tranches of $10 million (Coefficient SWVL Holdings, LLC), $3 million, and $1.5 million from separate investors, materially diluting existing shareholders and raising capital for working capital and U.S. expansion.
View raw filing on EDGAR →The Company entered into an at-the-market (ATM) sales agreement with Pacific Century Securities to offer and sell up to $35.3 million of Class A common stock. This is a registered direct equity offering that will dilute existing shareholders. ATM offerings are a classic form of dilutive equity issuance, and the magnitude ($35.3M) is material to a small-cap company trading on Nasdaq Capital Market.
View raw filing on EDGAR →BlackRock Private Credit Fund issued 245,505.01 Institutional Class Shares for $5,778,304 to feeder vehicles in an unregistered private placement exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →Addex announced the sale of 437,869 ADSs (representing 52,544,280 shares) for USD 2.8 million through an At the Market (ATM) offering agreement with H.C. Wainwright & Co. This is an unregistered equity issuance that dilutes existing shareholders. The disclosure explicitly states the outstanding shares increased to 210,292,217 shares, confirming material dilution. ATM offerings are a classic signal of capital-raising pressure at small- and mid-cap issuers.
View raw filing on EDGAR →Optimi Health entered into an equity line of credit (ELOC) with Seven Knots, LLC on August 13, 2026, granting the Company the right to sell up to US$100 million of common shares over the facility's term. The Company also issued convertible promissory notes (US$1.5 million initially, potentially US$500,000 more) convertible into common shares at 95% of the 20-day VWAP with a US$3.00 floor. This is a dilutive equity issuance arrangement that provides the Company with capital-raising flexibility while creating significant shareholder dilution risk, particularly given the convertible notes' favorable conversion terms and the ELOC's discretionary draw structure.
View raw filing on EDGAR →The Company issued 140,000 Class B Ordinary Shares to CEO/Chairman Pengfei Jiang at par value (US$350 total), which immediately grants him approximately 64.0% of aggregate voting power through a super-voting structure (30 votes per Class B share vs. 1 vote per Class A share). While the dollar amount is nominal, the dilutive effect and control concentration are material to investors assessing governance and ownership structure. This is a related-party equity issuance that materially shifts voting control, though the primary mechanism is super-voting rather than traditional dilution.
View raw filing on EDGAR →Alibaba completed an HK$80 billion placing of 710 million newly issued ordinary shares to non-U.S. persons at HK$112.70 per share under Regulation S, representing approximately 3.70% dilution to existing shareholders. The net proceeds of HK$79.7 billion are earmarked for AI infrastructure investment.
View raw filing on EDGAR →Vista Credit Strategic Lending Corp. completed an unregistered sale of 104,462.348 shares of Class I common stock for $1,995,000 to accredited investors and non-U.S. persons pursuant to subscription agreements, relying on Section 4(a)(2) and Regulation D/S exemptions.
View raw filing on EDGAR →The filing discloses the issuance of 23,031,494 Series A Common Warrants with an exercise price of $6.35 per share, which if exercised in full would provide approximately $146.2 million in capital. The warrants become exercisable upon the enrollment of the 500th subject in the ELAINE-3 Trial (triggered by this 8-K announcement), making this a material dilutive issuance. While the filing also announces a clinical trial milestone, the substantive disclosure centers on the warrant exercise mechanics and potential capital raise, characteristic of dilutive equity issuances.
View raw filing on EDGAR →Immatics announced an underwritten offering of 12,945,916 ordinary shares at $8.69 per share plus pre-funded warrants to purchase 4,315,304 ordinary shares, raising $150 million in gross proceeds. This is a registered public offering of equity securities that will dilute existing shareholders, fitting the definition of a dilutive issuance. The material size ($150M) and explicit warrant structure make this a significant capital-raising event material to investors.
View raw filing on EDGAR →Amendment to Pre-Paid Purchase agreement #1 originally issued July 6, 2026 ($1,080,000) modifying the share purchase price formula to 85% of the lowest VWAP over specified periods, materially altering the pricing terms for equity conversion and increasing dilution to existing shareholders.
View raw filing on EDGAR →Wetour Robotics entered into an at-the-market (ATM) sales agreement with Rodman & Renshaw LLC on August 26, 2026, to issue and sell ordinary shares from time to time. ATM offerings are unregistered equity issuances that are dilutive to existing shareholders and typically signal capital-raising activity at small- and mid-cap issuers. The agreement is registered under the company's Form F-3 shelf registration statement and permits sales on the Nasdaq Capital Market or other trading venues, with the sales agent receiving up to 3.0% commission.
View raw filing on EDGAR →The company issued unregistered TGL Shares to Developers under Section 4(a)(2) and Regulation S exemptions, with restricted stock status and Rule 144 compliance requirements, representing a material private placement and equity dilution.
View raw filing on EDGAR →Autonomix Medical entered into a warrant inducement agreement under which it issued unregistered Series E-1 and Series E-2 warrants (collectively 1,071,826 warrant shares) to an investor in exchange for the investor's exercise of existing warrants, generating approximately $4.9 million in gross proceeds. The new warrants are exercisable at $6.25 per share with 5-year terms and were issued pursuant to Section 4(a)(2) exemption as a private placement of unregistered equity securities.
View raw filing on EDGAR →Barrel Energy issued a $200,000 convertible note to CFI Capital LLC, generating $173,000 in net proceeds, with conversion rights at 60% of the lowest trading price and the ability to convert up to 9.9% of outstanding shares. The company reserved 11.1 million shares for conversion and agreed to maintain a 500% reserve, signaling substantial dilution potential to existing shareholders.
View raw filing on EDGAR →Item 3.02 discloses the conversion of 2,371,844 shares of Series B Preferred Stock into 118,592,200 shares of Common Stock on July 13, 2026, resulting in substantial dilution to existing shareholders. The conversion was effected without cash consideration and resulted in related parties (particularly Gope S. Kundnani and his affiliate Alchemy Prime Holdings Limited) receiving 99,592,200 shares, representing a material increase in their ownership proportion. This is a dilutive issuance of equity securities that would materially affect a reasonable investor's assessment of ownership and control.
View raw filing on EDGAR →InterCure completed a private placement on August 25, 2026, issuing 1,579,028 units (each comprising one ordinary share and one warrant) at $2.918 per unit, raising $5 million in gross proceeds plus approximately $2 million from CEO Rabinovich. This is a classic dilutive equity issuance exempt from registration under Section 4(a)(2) and Regulation S, materially affecting shareholder ownership and capital structure.
View raw filing on EDGAR →The filing discloses a private placement of 1,393,705 shares of common stock at $1.60 per share for approximately $2.23 million in gross proceeds, closed on August 26, 2026. Item 1.01 describes entry into a Securities Purchase Agreement and Item 3.02 explicitly confirms unregistered sales of equity securities under Section 4(a)(2) and Rule 506(d). This is a classic dilutive equity issuance that would materially affect existing shareholders' ownership percentages and is a strong signal of capital-raising activity typical at small- and mid-cap issuers.
View raw filing on EDGAR →The Company established an at-the-market (ATM) equity offering program on August 26, 2026, filing a prospectus supplement and entering into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald to offer and sell up to $2,625,000 of Class A common stock. This is a dilutive equity issuance that would materially affect existing shareholders through potential dilution and is a significant capital-raising event for the registrant.
View raw filing on EDGAR →The filing discloses under Item 3.02 an unregistered sale of 5,421 common shares of beneficial interest for approximately $0.1 million at $23.06 per share, exempt under Section 4(a)(2) and Regulation D Rule 506. This is a private placement of equity securities. While the August issuance amount is modest, the filing indicates the Company is "currently offering Shares on a monthly basis" as part of a continuous private offering, signaling ongoing dilutive capital raising activity material to investors assessing ownership dilution and the fund's capital structure.
View raw filing on EDGAR →HPS Corporate Capital Solutions Fund issued 872,284 common shares (121,953 Class I and 750,331 Class D) for total consideration of $23.73 million on August 1, 2026, pursuant to subscription agreements and exempt from Securities Act registration under Section 4(a)(2) and Regulations D/S.
View raw filing on EDGAR →Serina Therapeutics entered into a Common Stock Purchase Agreement with Roth Principal Investments granting the Company the right to sell up to $25,000,000 of newly issued common stock over 36 months at the Company's discretion, subject to a 19.99% exchange cap. The unregistered sale of common stock relies on Section 4(a)(2) and Rule 506(b) exemptions and represents a dilutive equity issuance to existing shareholders.
View raw filing on EDGAR →The filing discloses amendment of the certificate of incorporation to establish Series A-1 Convertible Preferred Stock in connection with closing of a private placement. While technically an Item 5.03 (bylaw/charter amendment), the material substance is the issuance of convertible preferred securities in a private placement, which is a dilutive capital raise. The reference to Item 1.01 of the prior 8-K (which typically covers material acquisitions and other transactions) and the explicit mention of "closing of its previously announced private placement" indicate this is a financing event, not a routine governance matter.
View raw filing on EDGAR →Black Hawk Acquisition Corp issued an unregistered convertible note that may be converted into shares of common stock upon closing of a DeSPAC transaction, relying on Section 4(a)(2) exemption. This dilutive issuance materially affects shareholder ownership and capital structure.
View raw filing on EDGAR →Stonepeak-Plus Infrastructure Fund LP sold approximately $44.9 million in unregistered limited partnership units to third-party investors on August 3, 2026, pursuant to a continuous private offering exempt under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Carlyle Private Equity Partners Fund sold approximately $13.4 million in unregistered limited partnership units to investors on August 1, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions, resulting in dilution to existing unitholders.
View raw filing on EDGAR →Thunder Mountain Gold closed a non-brokered private placement on August 20, 2026, issuing 8,090,451 units (each containing one common share and one-half warrant) for US$5.66 million in gross proceeds. The securities were issued outside the United States pursuant to Regulation S as restricted securities under the Securities Act, with additional finder warrants (94,089) issued to brokers.
View raw filing on EDGAR →Swvl announced a $13 million private placement (PIPE) of 8,990,317 Class A shares at $1.446 per share under Section 4(a)(2) of the Securities Act and Regulation D. This is an unregistered equity issuance that will dilute existing shareholders and raise capital for U.S. expansion and balance-sheet strengthening. The transaction is material to investors as it represents a significant capital raise and will result in Coefficient LP becoming the largest institutional shareholder with board representation.
View raw filing on EDGAR →The Fund entered into a distribution agreement authorizing the sale of up to $75 million in common shares through an at-the-market (ATM) offering, and commenced a public offering of Common Shares on August 25, 2026 pursuant to its Registration Statement.
View raw filing on EDGAR →The filing discloses an ongoing private placement offering of up to $2.165 billion of common shares across multiple classes, with $545.065 million already raised as of July 31, 2026. This represents a substantial dilutive equity issuance. While the disclosure also mentions dividend declarations and DRIP activity, the primary material event is the continuous private offering of common shares, which is a classic dilutive issuance requiring 8-K disclosure under Item 3.02.
View raw filing on EDGAR →